Publications by authors named "Chris Longshaw"

Claim this Profile
A
Activity of cefiderocol against from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance program.
John H Kimbrough, Maura H Karr, Sean T Nguyen, Boudewijn L M DeJonge, Chris Longshaw

Microbiol Spectr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placing in-vitro heteroresistance in the context of clinical results.
Matteo Bassetti, Roger Echols, Andrew Koren, Andreas Karas, Chris Longshaw

Lancet Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological Characterization and Clinical Outcomes After Extended-Pulsed Fidaxomicin Treatment for Infection in the EXTEND Study.
Mark H Wilcox, Oliver A Cornely, Benoit Guery, Chris Longshaw, Areti Georgopali

Open Forum Infect Dis· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.
Sarah A Kuehne, Andrew W Dempster, Mark M Collery, Nimitray Joshi, Jamie Jowett, Chris M Longshaw

J Antimicrob Chemother· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
Benoit Guery, Francesco Menichetti, Veli-Jukka Anttila, Nicholas Adomakoh, Jose Maria Aguado, Chris Longshaw

Lancet Infect Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.
Caroline H Chilton, Grace S Crowther, Helen Ashwin, Chris M Longshaw, Mark H Wilcox

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
Grace S Crowther, Caroline H Chilton, Chris Longshaw, Sharie L Todhunter, Duncan Ewin

J Antimicrob Chemother· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis